Amgen Stock (AMGN) News Today: TrumpRx Drug-Price Deal, FDA Approvals, Dividend Update, and 2026 Analyst Forecasts
December 20, 2025 — Amgen Inc. is closing out the year with a rare combination of near-term policy headlines and company-specific catalysts that matter…

















